Latest news from Olpha

Olpha will already be offering four new medicines on EU markets this year; next year their number will grow to at least 20

9th of July, 2024

By the end of this year, the leading Latvian pharmaceutical company and drug manufacturer JSC Olpha will offer four different new medicines in several European Union (EU) countries and the United Kingdom, which have passed the registration process and also met other regulatory requirements. The new drugs are intended for the treatment of urological, oncological and cardiovascular diseases. At least 18 new patent-free (generic) medicines are expected to enter the EU markets next year.

Read article

Contact us regarding media relations

Daiga Buča

Communications Manager

Cooperate with Olpha


For media relations and partnerships


For distributors and business partners

Social Cooperation

For social causes and potential projects


For open positions and career opportunties


Information on prescription medications should only be viewed by healthcare professionals.

Are you a health care worker?